Biocon signs supply deal with Medix for commercialization of generic Saxenda in Mexico

Briefs: Lupin and Aurobindo Pharma

Lupin updates on shipment of Mirabegron ER Tablets

Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr

The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024

Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr

Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024

Cipla receives 1 observation from USFDA for Kurkumbh facility

The company is committed to address this observation comprehensively within stipulated time

Vijaya Diagnostic Centre posts Q4 FY24 consolidated PAT at Rs. 33.45 Cr

The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024

Dr. Reddy's Laboratories launches Doxycycline Capsules, 40 mg in US

ORACEA is a trademark of Galderma Holdings, S.A.

Briefs: Eugia Pharma Specialities and IOL Chemicals and Pharmaceuticals

Eugia Pharma Specialities receives 7 observations from USFDA for Unit II

Tatva Chintan Pharma Chem posts Q4 FY24 PAT at Rs. 9.61 Cr

The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024

Glenmark receives ANDA approval for acetaminophen and ibuprofen tablets

Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA